Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study

Autores de IDIVAL

• 

  Victor Manuel Martínez Taboada

  Autor

  victormanuel.martinez@scsalud.es

• Leyre Riancho Zarrabeitia

  Autor

  leyre.riancho@scsalud.es

• Alejandra Comins Boo

  Autor

• 

  Marcos López Hoyos

  Autor

  marcos.lopez@scsalud.es

• 

  José Luís Hernández Hernández

  Autor

  joseluis.hernandez@scsalud.es

Autores ajenos al IDIVAL

• Del Barrio-Longarela S
• Blanco-Olavarri P
• Merino A

Abstract

The adjusted Global Antiphospholipid Syndrome (APS) Score (aGAPSS) is a tool proposed to quantify the risk for antiphospholipid antibody (aPL)-related clinical manifestations. However, aGAPSS has been validated mainly for thrombotic events and studies on APS-related obstetric manifestations are scarce. Furthermore, the majority of them included patients with positive aPL and different autoimmune diseases. Here, we assess the utility of aGAPSS to predict the response to treatment in aPL carriers without other autoimmune disorders. One-hundred and thirty-seven women with aPL ever pregnant were included. Sixty-five meet the APS classification criteria, 61 had APS-related obstetric manifestations, and 11 were asymptomatic carriers. The patients' aGAPSS risk was grouped as low (< 6, N = 73), medium (6-11, N = 40), and high risk (>= 12, N = 24). Since vascular risk factors included in the aGAPSS were infrequent in this population (< 10%), the aGAPSS score was mainly determined by the aPL profile. Overall, the live birth rate was 75%, and 37.2% of the patients had at least one adverse pregnancy outcome (APO). When considering patients according to the aGAPSS (high, medium, and low risk), no significant differences were found for pregnancy loss (29.2%, 25%, and 21.9%) or APO (33.3%, 47.5%, and 32.9%). In the present study, including aPL carriers without other autoimmune diseases, aGAPSS is not a valuable tool to identify patients at risk for obstetric complications despite treatment. In these patients with gestational desire, in addition to the aPL profile, other pregnancy-specific factors, such as age or previous obstetric history, should be considered.

© 2021. The Author(s).

Keywords

• GAPSS; Non-criteria obstetric manifestations; Pregnancy; Antiphospholipid syndrome; Antiphospholipid antibodies; Score